Deutsche Bank’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-10,147
| Closed | -$35K | – | 4800 |
|
|
2021
Q1 | $35K | Sell |
10,147
-933
| -8% | -$3.22K | ﹤0.01% | 4210 |
|
|
2020
Q4 | $37K | Buy |
11,080
+3,067
| +38% | +$10.2K | ﹤0.01% | 4073 |
|
|
2020
Q3 | $28K | Buy |
8,013
+730
| +10% | +$2.55K | ﹤0.01% | 3990 |
|
|
2020
Q2 | $34K | Buy |
7,283
+2,605
| +56% | +$12.2K | ﹤0.01% | 3898 |
|
|
2020
Q1 | $15K | Sell |
4,678
-276
| -6% | -$885 | ﹤0.01% | 3869 |
|
|
2019
Q4 | $29K | Sell |
4,954
-16,815
| -77% | -$98.4K | ﹤0.01% | 4034 |
|
|
2019
Q3 | $89K | Buy |
21,769
+10,700
| +97% | +$43.7K | ﹤0.01% | 3534 |
|
|
2019
Q2 | $143K | Buy |
+11,069
| New | +$143K | ﹤0.01% | 3923 |
|
|
2019
Q1 | – | Sell |
-2,136
| Closed | -$6K | – | 4929 |
|
|
2018
Q4 | $6K | Buy |
+2,136
| New | +$6K | ﹤0.01% | 4520 |
|